23 Jul, 2026
According to Straits Research, the global skincare devices market size was valued at $23.29 billion in 2025 and is projected to grow from $26.02 billion in 2026 to $64.92 billion by 2034, registering a CAGR of 12.11% during the forecast period 2026–2034.
The market growth is primarily attributed to the rising consumer demand for non-invasive and at-home skincare solutions, increasing awareness of advanced dermatological treatments, and rapid technological advancements in skincare devices. In addition, advancements in AI-powered diagnostic technologies are revolutionizing the early detection and management of skin disorders worldwide. For example, in January 2024, the U.S. Food and Drug Administration (FDA) granted clearance to DermaSensor's handheld device, making it the first AI-powered medical tool authorized to detect all three common skin cancers: melanoma, basal cell carcinoma, and squamous cell carcinoma. Such innovation not only enhances diagnostic accuracy but also enables timely intervention, ultimately improving patient outcomes and driving the adoption of advanced skincare devices in clinical settings. However, high cost and affordability constraints continue to restrain the skincare devices market. The high price of advanced and professional-grade devices limits accessibility for a large segment of consumers, particularly in emerging regions. Despite these challenges, the increasing preference for multifunctional, high-precision skincare devices among dermatology clinics and aesthetic centers presents a significant market opportunity. Clinics are seeking advanced devices that combine multiple therapies such as LED, radiofrequency, and microcurrent to deliver comprehensive treatments efficiently and effectively. Moreover, adopting these professional-grade devices allows clinics to differentiate themselves from competitors, enhance patient satisfaction, and expand service offerings, driving higher demand for innovative, clinic-focused skincare technologies.
sales@straitsresearch.com